Literature DB >> 24156473

Chemical tools to probe cellular O-GlcNAc signalling.

Adam Ostrowski1, Daan M F van Aalten.   

Abstract

Protein O-GlcNAcylation is an abundant, dynamic and reversible type of protein post-translational modification in animals that has been implicated in signalling processes linked to innate immunity, stress response, growth factor response, transcription, translation and proteosomal degradation. Only two enzymes, O-GlcNAc (O-linked N-acetylglucosamine) transferase and O-GlcNAcase, catalyse the reversible addition of the O-GlcNAc residue to over 1000 target proteins in the human cell. Recent advances in our understanding of the structures and mechanisms of these enzymes have resulted in the development of potent and selective inhibitors. The present review gives an overview of these inhibitors and how they have been used on cell lines, primary cells and animals to modulate O-GlcNAc levels and study the effects on signal transduction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24156473     DOI: 10.1042/BJ20131081

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  12 in total

1.  Aerobic glycolysis tunes YAP/TAZ transcriptional activity.

Authors:  Elena Enzo; Giulia Santinon; Arianna Pocaterra; Mariaceleste Aragona; Silvia Bresolin; Mattia Forcato; Daniela Grifoni; Annalisa Pession; Francesca Zanconato; Giulia Guzzo; Silvio Bicciato; Sirio Dupont
Journal:  EMBO J       Date:  2015-03-21       Impact factor: 11.598

Review 2.  Deciphering the Functions of Protein O-GlcNAcylation with Chemistry.

Authors:  Matthew Worth; Hao Li; Jiaoyang Jiang
Journal:  ACS Chem Biol       Date:  2017-01-19       Impact factor: 5.100

Review 3.  Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer.

Authors:  Andréia Vasconcelos-Dos-Santos; Isadora A Oliveira; Miguel Clodomiro Lucena; Natalia Rodrigues Mantuano; Stephen A Whelan; Wagner Barbosa Dias; Adriane Regina Todeschini
Journal:  Front Oncol       Date:  2015-06-25       Impact factor: 6.244

Review 4.  O-GlcNAcase: promiscuous hexosaminidase or key regulator of O-GlcNAc signaling?

Authors:  Jana Alonso; Marianne Schimpl; Daan M F van Aalten
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

5.  Higher O-GlcNAc Levels Are Associated with Defects in Progenitor Proliferation and Premature Neuronal Differentiation during in-Vitro Human Embryonic Cortical Neurogenesis.

Authors:  Shama Parween; Divya S Varghese; Mustafa T Ardah; Ashok D Prabakaran; Eric Mensah-Brown; Bright Starling Emerald; Suraiya A Ansari
Journal:  Front Cell Neurosci       Date:  2017-12-21       Impact factor: 5.505

6.  Model-based in silico analysis of the PI3K/Akt pathway: the elucidation of cross-talk between diabetes and breast cancer.

Authors:  Sammia Rehman; Ayesha Obaid; Anam Naz; Amjad Ali; Shahzina Kanwal; Jamil Ahmad
Journal:  PeerJ       Date:  2018-11-09       Impact factor: 2.984

7.  Evidence for a Functional O-Linked N-Acetylglucosamine (O-GlcNAc) System in the Thermophilic Bacterium Thermobaculum terrenum.

Authors:  Adam Ostrowski; Mehmet Gundogdu; Andrew T Ferenbach; Andrey A Lebedev; Daan M F van Aalten
Journal:  J Biol Chem       Date:  2015-10-21       Impact factor: 5.157

Review 8.  O-GlcNAcylation: The Sweet Side of the Cancer.

Authors:  Rafaela Muniz de Queiroz; Erika Carvalho; Wagner Barbosa Dias
Journal:  Front Oncol       Date:  2014-06-03       Impact factor: 6.244

Review 9.  The Role of Stress-Induced O-GlcNAc Protein Modification in the Regulation of Membrane Transport.

Authors:  Viktória Fisi; Attila Miseta; Tamás Nagy
Journal:  Oxid Med Cell Longev       Date:  2017-12-31       Impact factor: 6.543

10.  O-GlcNAcylation of FoxO1 mediates nucleoside diphosphate kinase B deficiency induced endothelial damage.

Authors:  Shenliang Shan; Anupriya Chatterjee; Yi Qiu; Hans-Peter Hammes; Thomas Wieland; Yuxi Feng
Journal:  Sci Rep       Date:  2018-07-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.